FDA Finalizes REMS Statutory Guidelines

Drug Industry Daily
A A
The FDA on Thursday released final guidance on how the agency will weigh the legally required factors when considering whether to require a risk evaluation mitigation strategy for medicines.

To View This Article:

Login

Subscribe To Drug Industry Daily